Obamacare Repeal Could Positively Impact Generic Companies

Barack Obama

The incoming Trump Administration is expected to make an Obamacare repeal a priority. According to Glenmark Pharmaceuticals, a repeal of the Affordable Care Act could significantly increase the generic companies’ share of the US drug market. Glenn Saldanha, Glenmark’s Chairman, went on to say he believed price erosion and pricing pressure in the US market are the new normal.

Read the source article at Bloomberg Quint

About the Author

Related Posts

Leave a Reply

*